Literature DB >> 25110406

Relationship between pouch microbiota and pouchitis following restorative proctocolectomy for ulcerative colitis.

Imerio Angriman1, Marco Scarpa1, Ignazio Castagliuolo1.   

Abstract

Restorative proctocolectomy with ileal pouch-anal anastomosis (IPAA) has become the surgical treatment of choice for many patients with medically refractory ulcerative colitis (UC) and familial adenomatous polyposis (FAP). UC patients with IPAA (UC-IPAA) are, nevertheless, susceptible to inflammatory and noninflammatory sequelae such as pouchitis, which is only rarely noted in FAP patients with IPAA. Pouchitis is the most frequent long-term complication of UC-IPAA patients, with a cumulative prevalence of up to 50%. Although the aetiology of pouchitis remains unclear, accumulating evidence suggests that a dysbiosis of the pouch microbiota and an abnormal mucosal immune response are implicated in its pathogenesis. Studies using culture and molecular techniques have detected a dysbiosis of the pouch microbiota in patients with pouchitis. Risk factors, genetic associations, and serological markers suggest that interactions between the host immune response and the pouch microbiota underlie the aetiology of this idiopathic inflammatory condition. This systematic review focuses on the dysbiosis of the microbiota that inhabit the pouch in UC and FAP patients and its interaction with the mucosal immune system. A meta-analysis was not attempted due to the highly heterogeneous microbiota composition and the different detection methods used by the various studies. Although no specific bacterial species, genus, or family has as yet been identified as pathogenic, there is evidence that a dysbiosis characterized by decreased gut microbiota diversity in UC-IPAA patients may, in genetically predisposed subjects, lead to aberrant mucosal immune regulation triggering an inflammatory process.

Entities:  

Keywords:  Bacteria; Crohn’s disease; Ileal-pouch-anal anastomosis; Inflammation of the ileal pouch; Inflammatory bowel disease; Microbiome; Microbiota; Pouchitis; Ulcerative colitis

Mesh:

Substances:

Year:  2014        PMID: 25110406      PMCID: PMC4123357          DOI: 10.3748/wjg.v20.i29.9665

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  90 in total

1.  Patterns of distribution of endoscopic and histological changes in the ileal reservoir after restorative proctocolectomy for ulcerative colitis. A long-term follow-up study.

Authors:  P G Setti Carraro; I C Talbot; J R Nicholls
Journal:  Int J Colorectal Dis       Date:  1998       Impact factor: 2.571

Review 2.  Pouchitis: risk factors, etiology, and treatment.

Authors:  R J Nicholls; A K Banerjee
Journal:  World J Surg       Date:  1998-04       Impact factor: 3.352

3.  Association of ulcerative colitis with rare VNTR alleles of the human intestinal mucin gene, MUC3.

Authors:  K Kyo; M Parkes; Y Takei; H Nishimori; P Vyas; J Satsangi; J Simmons; H Nagawa; S Baba; D Jewell; T Muto; G M Lathrop; Y Nakamura
Journal:  Hum Mol Genet       Date:  1999-02       Impact factor: 6.150

4.  Preoperative terminal ileal and colonic resection histopathology predicts risk of pouchitis in patients after ileoanal pull-through procedure.

Authors:  C M Schmidt; A J Lazenby; R J Hendrickson; J V Sitzmann
Journal:  Ann Surg       Date:  1998-05       Impact factor: 12.969

5.  Identification of defensin-1, defensin-2, and CAP37/azurocidin as T-cell chemoattractant proteins released from interleukin-8-stimulated neutrophils.

Authors:  O Chertov; D F Michiel; L Xu; J M Wang; K Tani; W J Murphy; D L Longo; D D Taub; J J Oppenheim
Journal:  J Biol Chem       Date:  1996-02-09       Impact factor: 5.157

6.  Prospective study of the incidence, timing and treatment of pouchitis in 104 consecutive patients after restorative proctocolectomy.

Authors:  R D Hurst; M Molinari; T P Chung; M Rubin; F Michelassi
Journal:  Arch Surg       Date:  1996-05

7.  n-butyrate downregulates the stimulatory function of peripheral blood-derived antigen-presenting cells: a potential mechanism for modulating T-cell responses by short-chain fatty acids.

Authors:  G A Böhmig; P M Krieger; M D Säemann; C Wenhardt; E Pohanka; G J Zlabinger
Journal:  Immunology       Date:  1997-10       Impact factor: 7.397

8.  Quantitative analysis of MUC2 synthesis in ulcerative colitis.

Authors:  K M Tytgat; J W van der Wal; A W Einerhand; H A Büller; J Dekker
Journal:  Biochem Biophys Res Commun       Date:  1996-07-16       Impact factor: 3.575

9.  Pouchitis after ileal pouch-anal anastomosis for ulcerative colitis occurs with increased frequency in patients with associated primary sclerosing cholangitis.

Authors:  C Penna; R Dozois; W Tremaine; W Sandborn; N LaRusso; C Schleck; D Ilstrup
Journal:  Gut       Date:  1996-02       Impact factor: 23.059

Review 10.  Clostridium difficile infection--an unusual cause of refractory pouchitis: report of a case.

Authors:  Steven D Mann; James Pitt; Roger G Springall; Andrew V Thillainayagam
Journal:  Dis Colon Rectum       Date:  2003-02       Impact factor: 4.585

View more
  10 in total

Review 1.  Japanese Society for Cancer of the Colon and Rectum (JSCCR) Guidelines 2016 for the Clinical Practice of Hereditary Colorectal Cancer (Translated Version).

Authors:  Hideyuki Ishida; Tatsuro Yamaguchi; Kohji Tanakaya; Kiwamu Akagi; Yasuhiro Inoue; Kensuke Kumamoto; Hideki Shimodaira; Shigeki Sekine; Toshiaki Tanaka; Akiko Chino; Naohiro Tomita; Takeshi Nakajima; Hirotoshi Hasegawa; Takao Hinoi; Akira Hirasawa; Yasuyuki Miyakura; Yoshie Murakami; Kei Muro; Yoichi Ajioka; Yojiro Hashiguchi; Yoshinori Ito; Yutaka Saito; Tetsuya Hamaguchi; Megumi Ishiguro; Soichiro Ishihara; Yukihide Kanemitsu; Hiroshi Kawano; Yusuke Kinugasa; Norihiro Kokudo; Keiko Murofushi; Takako Nakajima; Shiro Oka; Yoshiharu Sakai; Akihiko Tsuji; Keisuke Uehara; Hideki Ueno; Kentaro Yamazaki; Masahiro Yoshida; Takayuki Yoshino; Narikazu Boku; Takahiro Fujimori; Michio Itabashi; Nobuo Koinuma; Takayuki Morita; Genichi Nishimura; Yuh Sakata; Yasuhiro Shimada; Keiichi Takahashi; Shinji Tanaka; Osamu Tsuruta; Toshiharu Yamaguchi; Kenichi Sugihara; Toshiaki Watanabe
Journal:  J Anus Rectum Colon       Date:  2018-05-25

2.  A randomized double-blind placebo-controlled trial of a multi-strain probiotic in treatment of symptomatic uncomplicated diverticular disease.

Authors:  Charlotte L Kvasnovsky; Ingvar Bjarnason; Ana Nora Donaldson; Roy A Sherwood; Savvas Papagrigoriadis
Journal:  Inflammopharmacology       Date:  2017-05-20       Impact factor: 4.473

3.  Fecal Microbiota Transplantation in Pouchitis: Clinical, Endoscopic, Histologic, and Microbiota Results from a Pilot Study.

Authors:  Daniel Selvig; Yvette Piceno; Jonathan Terdiman; Martin Zydek; Sarah E Umetsu; Dana Balitzer; Doug Fadrosh; Kole Lynch; Brandon Lamere; Tom Leith; Zain Kassam; Kendall Beck; Sara Lewin; Averil Ma; Ma Somsouk; Susan V Lynch; Najwa El-Nachef
Journal:  Dig Dis Sci       Date:  2019-07-13       Impact factor: 3.199

Review 4.  A systematic review and meta-analysis of the outcome of ileal pouch-anal anastomosis in patients with ulcerative colitis versus patients with familial adenomatous polyposis.

Authors:  S H Emile; S M Khan; E Silva-Alvarenga; Z Garoufalia; S D Wexner
Journal:  Tech Coloproctol       Date:  2022-03-31       Impact factor: 3.699

5.  Host Immune Response to Clostridium difficile Infection in Inflammatory Bowel Disease Patients.

Authors:  Michelle Hughes; Taha Qazi; Adam Berg; Janice Weinberg; Xinhua Chen; Ciaran P Kelly; Francis A Farraye
Journal:  Inflamm Bowel Dis       Date:  2016-04       Impact factor: 5.325

6.  Japanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines 2020 for the Clinical Practice of Hereditary Colorectal Cancer.

Authors:  Naohiro Tomita; Hideyuki Ishida; Kohji Tanakaya; Tatsuro Yamaguchi; Kensuke Kumamoto; Toshiaki Tanaka; Takao Hinoi; Yasuyuki Miyakura; Hirotoshi Hasegawa; Tetsuji Takayama; Hideki Ishikawa; Takeshi Nakajima; Akiko Chino; Hideki Shimodaira; Akira Hirasawa; Yoshiko Nakayama; Shigeki Sekine; Kazuo Tamura; Kiwamu Akagi; Yuko Kawasaki; Hirotoshi Kobayashi; Masami Arai; Michio Itabashi; Yojiro Hashiguchi; Kenichi Sugihara
Journal:  Int J Clin Oncol       Date:  2021-06-29       Impact factor: 3.402

7.  Dietary antioxidant micronutrients alter mucosal inflammatory risk in a murine model of genetic and microbial susceptibility.

Authors:  Joseph F Pierre; Reinhard Hinterleitner; Romain Bouziat; Nathan A Hubert; Vanessa Leone; Jun Miyoshi; Bana Jabri; Eugene B Chang
Journal:  J Nutr Biochem       Date:  2017-12-10       Impact factor: 6.048

8.  Insights into the pathogenesis of ulcerative colitis from a murine model of stasis-induced dysbiosis, colonic metaplasia, and genetic susceptibility.

Authors:  Marc A Ward; Joseph F Pierre; Raquel F Leal; Yong Huang; Benjamin Shogan; Sushila R Dalal; Christopher R Weber; Vanessa A Leone; Mark W Musch; Gary C An; Mrinalini C Rao; David T Rubin; Laura E Raffals; Dionysios A Antonopoulos; Mitch L Sogin; Neil H Hyman; John C Alverdy; Eugene B Chang
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2016-04-14       Impact factor: 4.052

Review 9.  Postoperative changes of the microbiome: are surgical complications related to the gut flora? A systematic review.

Authors:  Ann-Kathrin Lederer; Przemyslaw Pisarski; Lampros Kousoulas; Stefan Fichtner-Feigl; Carolin Hess; Roman Huber
Journal:  BMC Surg       Date:  2017-12-04       Impact factor: 2.102

10.  Effects of Bifidobacterium animalis ssp. lactis 420 on gastrointestinal inflammation induced by a nonsteroidal anti-inflammatory drug: A randomized, placebo-controlled, double-blind clinical trial.

Authors:  Sanna M Mäkelä; Sofia D Forssten; Marita Kailajärvi; Ville L Langén; Mika Scheinin; Kirsti Tiihonen; Arthur C Ouwehand
Journal:  Br J Clin Pharmacol       Date:  2021-05-30       Impact factor: 3.716

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.